- Report
- January 2024
- 80 Pages
Argentina
From €1369EUR$1,500USD£1,163GBP
- Report
- February 2025
- 73 Pages
China
From €5470EUR$5,995USD£4,648GBP
- Report
- February 2025
- 155 Pages
United States
From €5470EUR$5,995USD£4,648GBP
- Report
- January 2025
- 132 Pages
Global
From €867EUR$950USD£737GBP
- Report
- March 2022
- 254 Pages
Global
From €2277EUR$2,496USD£1,935GBP
€3253EUR$3,565USD£2,764GBP
- Report
- July 2024
- 216 Pages
Global
From €1696EUR$1,859USD£1,441GBP
€2423EUR$2,655USD£2,059GBP
- Report
- February 2023
- 284 Pages
Global
From €2280EUR$2,499USD£1,938GBP
€3258EUR$3,570USD£2,768GBP
- Report
- May 2022
- 220 Pages
Global
From €2208EUR$2,419USD£1,876GBP
€3154EUR$3,456USD£2,680GBP
- Report
- April 2022
- 180 Pages
Global
From €2277EUR$2,496USD£1,935GBP
€3253EUR$3,565USD£2,764GBP
- Report
- September 2023
- 314 Pages
Global
From €2280EUR$2,499USD£1,938GBP
€3258EUR$3,570USD£2,768GBP
- Report
- June 2023
- 80 Pages
Saudi Arabia
From €1389EUR$1,523USD£1,181GBP
€1985EUR$2,175USD£1,686GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more